Antidiabetic Medication Utilisation before and during Pregnancy in Switzerland between 2012 and 2019: An Administrative Claim Database from the MAMA Cohort

Figure 2

Proportion of pregnancies in which a given ADM was continued, switched, or discontinued, among pregnancies exposed to an ADM during the prepregnancy period between 2012 and 2019. Insulin in prepregnancy and then insulin and blood glucose-lowering drugs in or after T2 (); insulin and blood glucose-lowering drugs in prepregnancy and insulin only in or after T2 (); insulin and blood glucose-lowering drugs both in prepregnancy and in or after T2 (); blood glucose-lowering drugs in prepregnancy and blood glucose-lowering drugs + insulin in or after T2 ().